Cannabinoids, used for centuries for recreational and medical purposes, have potential therapeutic value in stroke treatment. Cannabidiol (CBD), a non-psychoactive compound and partial agonist of TRPV2 channels, is efficacious in many neurological disorders. We investigated the effects of CBD or Δ9-tetrahydrocannabinol (THC) in rat organotypic hippocampal slices exposed to oxygen-glucose deprivation (OGD), an in vitro model of ischemia. Neuronal TRPV2 expression decreased after OGD, but it increased in activated, phagocytic microglia. CBD increased TRPV2 expression, decreased microglia phagocytosis, and increased rod microglia after OGD. THC had effects contrary to those of CBD. Our results show that cannabinoids have different effects in ischemia. CBD showed neuroprotective effects, mediated, at least in part, by TRPV2 channels, since the TRPV2 antagonist tranilast blocked them, while THC worsened the neurodegeneration caused by ischemia. In conclusion, our results suggest that different cannabinoid molecules play different roles in the mechanisms of post-ischemic neuronal death. These different effects of cannabinoid observed in our experiments caution against the indiscriminate use of cannabis or cannabinoid preparations for recreational or therapeutic use. It was observed that the positive effects of CBD may be counteracted by the negative effects caused by high levels of THC.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9603301PMC
http://dx.doi.org/10.3390/ijms232012144DOI Listing

Publication Analysis

Top Keywords

trpv2 channels
8
effects cbd
8
trpv2 expression
8
expression decreased
8
effects
7
trpv2
6
cbd
6
protective cbd
4
cbd model
4
model vitro
4

Similar Publications

Background: Transient receptor potential cation channel subfamily V member 2 (TRPV2) functions as a stretch-sensitive calcium channel, with overexpression in the sarcolemma of skeletal and cardiac myocytes leading to detrimental calcium influx and triggering muscle degeneration. In our previous pilot study, we showed that tranilast, a TRPV2 inhibitor, reduced brain natriuretic peptide levels in two patients with muscular dystrophy and advanced heart failure. Building on this, we performed a single-arm, open-label, multicenter study herein to evaluate the safety and efficacy of tranilast in the treatment of advanced heart failure in patients with muscular dystrophy.

View Article and Find Full Text PDF

Duck Tembusu virus (DTMUV), a novel positive-sense RNA virus, has caused significant economic losses in the poultry industry of Eastern and Southeast Asia since its outbreak in 2010. Furthermore, the rapid transmission and potential zoonotic nature of DTMUV pose a threat to public health safety. In this study, a 4D-DIA quantitative proteomics approach was employed to identify differentially expressed cellular proteins in DTMUV-infected DF-1 cells, which are routinely used for virus isolation and identification for DTMUV, as well as the development of vaccines against other poultry viruses.

View Article and Find Full Text PDF

Impaired function of the retinal neurovascular unit (NVU) is an early event in diabetic retinopathy (DR). It has been previously shown that topical delivery of the dipeptidyl peptidase-4 (DPP-4) inhibitor sitagliptin can protect against diabetes-mediated dysfunction of the retinal NVU in the db/db mouse. The aim of the present study was to examine whether sitagliptin could prevent the DR-like lesions within the NVU of the new non-diabetic model of DR, the Trpv2 knockout rat (Trpv2).

View Article and Find Full Text PDF
Article Synopsis
  • The study investigates the role of mechanosensitive channels (MSCs) in the retina, particularly how they relate to conditions like glaucoma and retinal injuries caused by increased pressure.
  • Using advanced techniques, the researchers analyzed the expression of various MSCs in different retinal cells, including Müller cells and retinal ganglion cells (RGCs).
  • They found a critical balance between hyperpolarizing and depolarizing MSCs in retinal neurons, suggesting that this balance may affect how vulnerable these neurons are to pressure-induced damage, highlighting potential new avenues for treatment.
View Article and Find Full Text PDF

Qisheng wan decoction alleviates the inflammation of CCI rats via TRP channels.

J Ethnopharmacol

February 2025

School of Life Science and Engineering, Southwest Jiaotong University, Chengdu, China. Electronic address:

Article Synopsis
  • Qisheng wan decoction (QWD) is a traditional Chinese medicine showing potential for reducing neuropathic pain (NP) through anti-inflammatory effects, although its active components and mechanisms are not fully understood.
  • The study aimed to identify QWD's active ingredients using a combination of advanced analytical techniques and network pharmacology, and to investigate its anti-inflammatory mechanisms in a rat model of NP induced by chronic constriction injury.
  • Seventy compounds from QWD were identified, along with seven key targets related to inflammation, highlighting the decoction's complex interactions and potential effectiveness against NP.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!